Epkinly is a prescription cancer medicine that contains the active ingredient epcoritamab-bysp. It is a type of immunotherapy known as a bispecific CD20-directed CD3 T-cell engager, designed to help the body’s immune system recognize and destroy certain cancerous B cells.

Erbitux is the brand name for cetuximab, a monoclonal antibody used in the treatment of certain types of cancer. It belongs to a class of targeted therapies known as epidermal growth factor receptor (EGFR) inhibitors.

Evermil 5 Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.

Folotyn is primarily used to treat:

• Peripheral T-cell lymphoma (PTCL) in patients whose disease has relapsed or not responded to other treatments.

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Glumetinib  is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition factor (MET) exon 14 skipping mutations (METex14 skipping).

Hernexeos (Zongertinib): A Targeted Therapy for HER2-Mutant Non-Small Cell Lung Cancer

Zongertinib is a next-generation, oral tyrosine kinase inhibitor (TKI) developed for the treatment of patients with HER2-mutant non-small cell lung cancer (NSCLC).

Hyrnuo is indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating HER2 (ERBB2) mutations, who have received at least one prior systemic therapy.

IMFINZI Injection (Durvalumab): An Advanced Immunotherapy for Cancer Treatment IMFINZI Injection contains durvalumab, a monoclonal antibody that belongs to a class of medicines known as immune checkpoint inhibitors. It is designed to help the body’s immune system recognize and attack cancer cells more effectively. Unlike traditional chemotherapy, which directly targets rapidly dividing cells, IMFINZI works…

Iressa is a prescription cancer medicine used mainly in the treatment of non-small cell lung cancer (NSCLC), particularly in patients whose tumors have specific mutations in the epidermal growth factor receptor (EGFR) gene. What Iressa is used for Iressa is primarily prescribed for: Advanced or metastatic non-small cell lung cancer (NSCLC) Patients with EGFR mutation-positive…

KEYTRUDA (Pembrolizumab): Advancing Cancer Care Through Immunotherapy

Lenalidomide 10 mg is an immunomodulatory medicine used in the treatment of certain blood cancers and blood-related disorders. It works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of blood vessels that support tumor growth.

Lenalidomide 15 mg is an immunomodulatory medication used in the treatment of certain blood cancers and hematologic disorders. It belongs to a class of drugs known as immunomodulatory agents and works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of blood vessels that support tumor growth.